Current Report Filing (8-k)
March 31 2020 - 04:35PM
Edgar (US Regulatory)
0001320414
false
0001320414
2020-03-30
2020-03-31
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
current
report
Pursuant to Section
13 or 15(d) of the
Securities Exchange
Act of 1934
Date of
Report (Date of earliest event reported): March 31, 2020
SELECT MEDICAL HOLDINGS CORPORATION
(Exact name of registrant as specified in
its charter)
Delaware
|
|
001-34465
|
|
20-1764048
|
(State or other jurisdiction of
Incorporation)
|
|
(Commission File
Number)
|
|
(I.R.S. Employer
Identification No.)
|
4714 Gettysburg Road, P.O. Box 2034
Mechanicsburg, PA 17055
(Address of principal executive offices) (Zip Code)
(717) 972-1100
(Registrant’s telephone number, including
area code)
Securities registered pursuant to Section
12(b) of the Act:
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
Common Stock, par value $0.001 per share
|
SEM
|
New York Stock Exchange (NYSE)
|
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate by check mark whether either registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ¨
If an emerging growth company, indicate by check mark if either
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act. ¨
On March 31, 2020, Select Medical Holdings
Corporation (the “Company”) announced a change in the location of the Company’s 2020 Annual Meeting of Stockholders
to be held on Tuesday, April 28, 2020 (the “Annual Meeting”). A copy of the press release announcing the location change
is attached hereto as Exhibit 99.1 and is incorporated by reference herein. Further information regarding this change to the location
of the Annual Meeting can be found in the proxy supplement filed by the Company with the Securities and Exchange Commission on
March 31, 2020.
Item 9.01
|
Financial Statements and Exhibits.
|
(d) Exhibits.
SIGNATURE
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrants have duly caused this report to be signed on their behalf by the undersigned,
thereunto duly authorized.
|
SELECT MEDICAL HOLDINGS CORPORATION
|
|
|
Date: March 31, 2020
|
By:
|
/s/ Michael E. Tarvin
|
|
|
Michael E. Tarvin
|
|
|
Executive Vice President, General Counsel and Secretary
|
Select Medical (NYSE:SEM)
Historical Stock Chart
From Feb 2024 to Mar 2024
Select Medical (NYSE:SEM)
Historical Stock Chart
From Mar 2023 to Mar 2024